Skip to main content
padlock icon - secure page this page is secure

Accelerated Partial Breast Irradiation- Pros and Cons

Buy Article:

$68.00 + tax (Refund Policy)

Breast conservation surgery followed by whole breast irradiation has been established as a standard of care for the treatment of early stage breast cancer and is associated with excellent local control and overall survival. As most inbreast recurrences occur in the area surrounding the primary breast cancer, it has been hypothesized that selected breast cancer patients may be adequately treated with accelerated partial breast irradiation (APBI), obviating the need for whole breast irradiation. Advantages of APBI include a shorter treatment schedule that may result in perceived patient convenience and more women opting for breast conservation therapy. These possible benefits of APBI must be balanced with the potential risk of recurrence within untreated breast tissue and the possible long term toxicity associated with larger doses per fraction and accelerated course of irradiation. Although, the preliminary results with APBI are encouraging, appropriate patient selection and optimal dosimetric guidelines remain to be clearly defined.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 3D conformal external beam radiotherapy; American Society of Radiation Oncology (ASTRO); BRCA1/BRCA2 mutations; Bowel Project; Breast cancer; Direct visualization; Iridium192; Single Balloon-Catheter (MammoSite) Technique; accelerated partial breast irradiation; biologically effective doses; brachytherapy; breast conservation therapy; breast tissue; computed tomography; cosmetic results; ductal carcinomas; fractionation; intraoperative radiation; lumpectomy; lymph node-negative breast cancer; lymph node-positive patients; lymph nodes; mammographic-histologic techniques; mastectomy specimens; multicentricity; multifocality; necrosis; nonlobular breast cancer histology; prognostic factors; quadrantectomy; radiation dose; radiobiological equivalent; radiotherapy; residual carcinoma; retrospective matched-pair study analysis; seroma formation rates; surgical clips; tumor foci; ultrasound

Document Type: Research Article

Publication date: January 1, 2011

More about this publication?
  • Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I - IV clinical trial studies, clinical investigations at all stages of development and therapeutics.

    The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more